MENU
VCEL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Vericel (VCEL) Earnings Date & Reports

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets... Show more

A.I. Advisor
published Earnings

VCEL is expected to report earnings to rise 317.40% to 41 cents per share on February 26

Vericel VCEL Stock Earnings Reports
Q4'25
Est.
$0.42
Q3'25
Beat
by $0.11
Q2'25
Beat
by $0.02
Q1'25
Missed
by $0.10
Q4'24
Beat
by $0.07
The last earnings report on November 06 showed earnings per share of 10 cents, beating the estimate of 0 cents. With 435.35K shares outstanding, the current market capitalization sits at 2.01B.
View a ticker or compare two or three
VCEL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. VCEL showed earnings on November 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of patient-specific expanded cellular therapies for use in the treatment of patients with diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
64 Sidney Street
Phone
+1 617 588-5555
Employees
314
Web
https://www.vcel.com